Sponsor Pipeline

Hangzhou Yirui Pharmaceutical Technology Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-31 NCT07285967
A First-in-Human SAD and MAD Study in Healthy Participants to Evaluate Oral YR011 Tablet		 date change Primary completion pushed: 2026-09-30 -> 2027-09-30
2026-07-31 NCT07285967
A First-in-Human SAD and MAD Study in Healthy Participants to Evaluate Oral YR011 Tablet		 date change Completion pushed: 2026-12-31 -> 2027-12-31
Active Trials by Phase
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07673458 An Early-stage Clinical Trial to Evaluate the Safety, Absorption, and Disposition of… Health Adult Subjects Recruiting
NCT07285967 A First-in-Human SAD and MAD Study in Healthy Participants to Evaluate Oral YR011 Tablet Safety Not Yet Recruiting
Get alerts when Hangzhou Yirui Pharmaceutical Technology Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free